These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10980532)

  • 21. Molecular analysis and prenatal prediction of spinal muscular atrophy in Chinese patients by the combination of restriction fragment length polymorphism analysis, denaturing high-performance liquid chromatography, and linkage analysis.
    Chen WJ; Wu ZY; Lin MT; Su JF; Lin Y; Murong SX; Wang N
    Arch Neurol; 2007 Feb; 64(2):225-31. PubMed ID: 17296838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
    J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a reliable method for detection of non-homozygous patients with spinal muscular atrophy].
    Long MJ; Song F; Qu YJ; Meng Y; Wang H; Jin YW; Huang SZ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1259-63. PubMed ID: 18844099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic risk assessment in carrier testing for spinal muscular atrophy.
    Ogino S; Leonard DG; Rennert H; Ewens WJ; Wilson RB
    Am J Med Genet; 2002 Jul; 110(4):301-7. PubMed ID: 12116201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinal muscular atrophy diagnostics.
    Prior TW
    J Child Neurol; 2007 Aug; 22(8):952-6. PubMed ID: 17761649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duplications and de novo deletions of the SMNt gene demonstrated by fluorescence-based carrier testing for spinal muscular atrophy.
    Chen KL; Wang YL; Rennert H; Joshi I; Mills JK; Leonard DG; Wilson RB
    Am J Med Genet; 1999 Aug; 85(5):463-9. PubMed ID: 10405443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy.
    Arkblad EL; Darin N; Berg K; Kimber E; Brandberg G; Lindberg C; Holmberg E; Tulinius M; Nordling M
    Neuromuscul Disord; 2006 Dec; 16(12):830-8. PubMed ID: 17049859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy.
    Taylor JE; Thomas NH; Lewis CM; Abbs SJ; Rodrigues NR; Davies KE; Mathew CG
    Eur J Hum Genet; 1998; 6(5):467-74. PubMed ID: 9801871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High incidence of SMN1 gene deletion in Moroccan adult-onset spinal muscular atrophy patients.
    Bouhouche A; Benomar A; Birouk N; Bouslam N; Ouazzani R; Yahyaoui M; Chkili T
    J Neurol; 2003 Oct; 250(10):1209-13. PubMed ID: 14586604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinal muscular atrophy carrier screening by multiplex polymerase chain reaction using dried blood spot on filter paper.
    Majumdar R; Rehana Z; Al Jumah M; Fetaini N
    Ann Hum Genet; 2005 Mar; 69(Pt 2):216-21. PubMed ID: 15720302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells.
    Boda B; Mas C; Giudicelli C; Nepote V; Guimiot F; Levacher B; Zvara A; Santha M; LeGall I; Simonneau M
    Eur J Hum Genet; 2004 Sep; 12(9):729-37. PubMed ID: 15162126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of SMN2 copy number and NAIP deletion predicts disease severity in spinal muscular atrophy.
    Watihayati MS; Fatemeh H; Marini M; Atif AB; Zahiruddin WM; Sasongko TH; Tang TH; Zabidi-Hussin ZA; Nishio H; Zilfalil BA
    Brain Dev; 2009 Jan; 31(1):42-5. PubMed ID: 18842367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of the spinal muscular atrophy and neuronal apoptosis inhibitory protein genes in Saudi patients with spinal muscular atrophy.
    Al-Jumah M; Majumdar R; Al-Rajeh S; Awada A; Chaves-Carbello E; Salih M; Al-Shahwan S; Al-Subiey K; Al-Uthaim S
    Saudi Med J; 2003 Oct; 24(10):1052-4. PubMed ID: 14578966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular analysis of SMA patients without homozygous SMN1 deletions using a new strategy for identification of SMN1 subtle mutations.
    Clermont O; Burlet P; Benit P; Chanterau D; Saugier-Veber P; Munnich A; Cusin V
    Hum Mutat; 2004 Nov; 24(5):417-27. PubMed ID: 15459957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid diagnosis of spinal muscular atrophy using tetra-primer ARMS PCR assay: simultaneous detection of SMN1 and SMN2 deletion.
    Baris I; Etlik O; Koksal V; Arican-Baris ST
    Mol Cell Probes; 2010 Jun; 24(3):138-41. PubMed ID: 20025960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy.
    Jarecki J; Chen X; Bernardino A; Coovert DD; Whitney M; Burghes A; Stack J; Pollok BA
    Hum Mol Genet; 2005 Jul; 14(14):2003-18. PubMed ID: 15944201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quantitative analysis of the genes determining spinal muscular atrophy].
    Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
    Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Best practice guidelines for molecular analysis in spinal muscular atrophy.
    Scheffer H; Cobben JM; Matthijs G; Wirth B
    Eur J Hum Genet; 2001 Jul; 9(7):484-91. PubMed ID: 11464239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of deletional damage in SMN1, SMN2, and NAIP genes in patients with spinal muscular atrophy in the northwestern region of Russia].
    Glotov AS; Kiselev AV; Ivashchenko TE; Baranov VS
    Genetika; 2001 Aug; 37(8):1156-9. PubMed ID: 11642117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SMA carrier testing--validation of hemizygous SMN exon 7 deletion test for the identification of proximal spinal muscular atrophy carriers and patients with a single allele deletion.
    Scheffer H; Cobben JM; Mensink RG; Stulp RP; van der Steege G; Buys CH
    Eur J Hum Genet; 2000 Feb; 8(2):79-86. PubMed ID: 10757638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.